Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Hydrochlorothiazide-olmesartan

Severity: Minor

Glecaprevir / pibrentasvir and Hydrochlorothiazide-olmesartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir inhibit hepatic uptake transporters OATP1B1 and OATP1B3, which can raise olmesartan plasma concentrations. This may enhance blood pressure lowering and adverse effects of olmesartan.

What this interaction means in plain words

Glecaprevir / pibrentasvir and Hydrochlorothiazide-olmesartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Inhibition of OATP1B1/1B3-mediated hepatic uptake of olmesartan.

What to do

Monitor blood pressure and renal function during the hepatitis C treatment course. Reduce olmesartan dose if hypotension occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Hydrochlorothiazide-olmesartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Hydrochlorothiazide-olmesartan?

MediHelp rates the interaction as minor. Glecaprevir / pibrentasvir and Hydrochlorothiazide-olmesartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Glecaprevir and pibrentasvir inhibit hepatic uptake transporters OATP1B1 and OATP1B3, which can raise olmesartan plasma concentrations. This may enhance blood pressure lowering and adverse effects of olmesartan.

How serious is the interaction between Glecaprevir / pibrentasvir and Hydrochlorothiazide-olmesartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and renal function during the hepatitis C treatment course. Reduce olmesartan dose if hypotension occurs.

What other medicines interact with Hydrochlorothiazide-olmesartan?

MediHelp also lists interactions of Hydrochlorothiazide-olmesartan with, for example, Aliskiren, Dofetilide, Sparsentan. The full list is on the Hydrochlorothiazide-olmesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in